Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4+CD25high T Cells

Yamamoto, Yoshiki; Negoro, Takaharu; Tada, Rui; Narushima, Michiaki; Hoshi, Akane; Negishi, Yoichi; Nakano, Yasuko

doi:10.3390/biomedicines9060616

Open AccessArticle

Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4⁺CD25^high T Cells

¹

Department of Paediatrics, Tokyo Metropolitan Ebara Hospital, Tokyo 145-0065, Japan

²

Department of Pharmacogenomics, School of Pharmacy, Showa University, Tokyo 142-8555, Japan

³

Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan

⁴

Department of Internal Medicine, Showa University Northern Yokohama Hospital, Kanagawa 224-8503, Japan

^*

Authors to whom correspondence should be addressed.

Biomedicines 2021, 9(6), 616; https://doi.org/10.3390/biomedicines9060616

Submission received: 7 May 2021 / Revised: 25 May 2021 / Accepted: 25 May 2021 / Published: 29 May 2021

(This article belongs to the Special Issue Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches 2.0)

Download

Browse Figures

Versions Notes

Abstract

:

Conversion of CD4⁺CD25⁺FOXP3⁺ T regulatory cells (T_regs) from the immature (CD45RA⁺) to mature (CD45RO⁺) phenotype has been shown during development and allergic reactions. The relative frequencies of these T_reg phenotypes and their responses to oxidative stress during development and allergic inflammation were analysed in samples from paediatric and adult subjects. The FOXP3^lowCD45RA⁺ population was dominant in early childhood, while the percentage of FOXP3^highCD45RO⁺ cells began increasing in the first year of life. These phenotypic changes were observed in subjects with and without asthma. Further, there was a significant increase in phosphorylated ERK1/2 (pERK1/2) protein in hydrogen peroxide (H₂O₂)-treated CD4⁺CD25^high cells in adults with asthma compared with those without asthma. Increased pERK1/2 levels corresponded with increased Ca²⁺ response to T cell receptor stimulation. mRNA expression of peroxiredoxins declined in T_regs from adults with asthma. Finally, CD4⁺CD25^high cells from paediatric subjects were more sensitive to oxidative stress than those from adults in vitro. The differential T_reg sensitivity to oxidative stress observed in children and adults was likely dependent on phenotypic CD45 isoform switching. Increased sensitivity of T_reg cells from adults with asthma to H₂O₂ resulted from a reduction of peroxiredoxin-2, -3, -4 and increased pERK1/2 via impaired Ca²⁺ response in these cells.

Keywords:

allergy; CD45 isoform; extracellular signal-regulated kinases 1/2; oxidative stress; regulatory T cell

1. Introduction

Regulatory T cells (T_regs) play critical roles in allergic immune response regulation [1,2,3]. Airway inflammation in paediatric asthma is associated with infiltrating Th2 cells and eosinophils triggered by allergens [4], and most children with asthma are atopic in Japan [5]. Numerous studies have shown that reduced T_reg cells [6], decreased levels of forkhead box P3 (FOXP3) protein, a master transcriptional regulator of T_reg cells [6,7,8,9], and impaired T_reg function result in the loss of control of inflammation [8,10,11,12]. However, several reports have demonstrated increases in the number of T_regs during exacerbation of asthma [13,14] and elevated T_reg numbers and FOXP3 expression after allergen challenge [15] or glucocorticoid treatment [7,16,17].

Studies have identified that several T_reg subtypes, such as thymus-derived T_regs (tT_regs) and peripherally derived T_regs (pT_regs), are involved in the regulation of airway inflammation [18,19,20]. T_reg maturation that occurs during development can be detected by a shift in the expression of isoforms of the CD45 surface antigen from CD45RA to CD45RO. This phenotypic switch is a marker of T cell differentiation [21,22,23]: CD45RA⁺ expression is characteristic of naïve T cells before antigen exposure, whereas CD45RO⁺ T cells are memory T cells that have been exposed to antigen. Miyara et al. demonstrated that immature FOXP3^lowCD45RA⁺ T_reg cells could differentiate to mature FOXP3^highCD45RA⁻ T_reg cells, which were very similar to CD45RO⁺ T_reg cells [23]. The cells with the immature phenotype accounted for a substantial fraction of T_reg cells in children, whereas the cells with the mature phenotype were dominant in adults. Whereas numerous studies have assessed T_reg subtypes in the cord blood and adult peripheral blood, T_reg CD45 isoform phenotypic switching during early childhood development has not been examined in allergic subjects. Thus, here we compared changes during development and those with regard to allergies in early childhood.

Mougiakakos et al. reported that the production of high levels of thioredoxin-1 by T_reg cells conferred protection against cell death triggered by hydrogen peroxide (H₂O₂)-mediated oxidative stress [24]. H₂O₂ induces several cellular responses, including the activation of MAP kinase, chemokine production, and apoptosis [24,25,26]. In this study, tolerance to oxidative stress in T_regs was compared in paediatric subjects with and without allergy by the assessment of phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK). Moreover, adults with or without asthma were compared with paediatric subjects. Finally, antioxidant stress-related patterns of gene expression were assessed by microarray profiling of Jurkat cells with doxycyline (Dox)-inducible FOXP3.

2. Materials and Methods

2.1. Subjects

Paediatric subjects, 11 with and 38 without allergy, were recruited at the Showa University Hospital and Tokyo Metropolitan Ebara Hospital between July and December 2004 and between December 2006 and January 2007. Characteristics of all the paediatric subjects are shown in Table 1. The age of paediatric subjects with allergy ranged from 11 months to 13 years and 3 months, and the average age was 4 years and 8 months. The age of paediatric subjects without allergy ranged from 3 months to 8 years and 2 months, and the average age of this group was comparable to that of the allergic paediatric cases. Allergic diseases mainly consist of asthma, allergic rhinitis, atopic dermatitis, and food allergy. The majority of allergic subjects had two or more allergic diseases, and eight of these had simultaneous food allergy and atopic dermatitis. Adult subjects, 10 with and 6 without asthma, were recruited at Showa University Hospital and Showa University Fujigaoka Hospital between July and October 2004 (Table 1). Asthma was defined according to the criteria established by the 1998 Japanese guidelines, the Japanese Pediatric Guidelines for the Treatment and Management of Asthma 2004, and the Global Initiative for Asthma as revised in 2002. Atopic dermatitis and food allergy were defined according to the criteria established by the Japanese Guideline for Atopic Dermatitis 2004 and the Japanese Guideline for Diagnosis and Management of Food Allergy 2005, respectively. All subjects with allergy completed a standard questionnaire regarding allergy symptoms, and atopy was established by the measurement of serum-specific IgE to common allergens such as mite, mold, pet allergens, pollen, and food allergens (CAP RAST system; Pharmacia Diagnostics AB, Uppsala, Sweden). This study was approved by the Showa University Medical Ethics Committee (protocol number 310 for paediatric subjects, protocol number 2002022 for adult subjects) and the Tokyo Metropolitan Ebara Hospital Trust local research and ethics committee. Written informed consent was obtained from all participants or their guardians in accordance with the ethical guidelines of the Declaration of Helsinki: The Materials and Methods should be described with sufficient details to allow others to replicate and build on the published results. Please note that the publication of your manuscript implicates that you must make all materials, data, computer code, and protocols associated with the publication available to readers. Please disclose at the submission stage any restrictions on the availability of materials or information. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited.

Research manuscripts reporting large datasets that are deposited in a publicly available database should specify where the data have been deposited and provide the relevant accession numbers. If the accession numbers have not yet been obtained at the time of submission, please state that they will be provided during review. They must be provided prior to publication.

Interventionary studies involving animals or humans, and other studies that require ethical approval, must list the authority that provided approval and the corresponding ethical approval code.

2.2. Flow Cytometry

2.2.1. Cells

Peripheral blood mononuclear cells (PBMCs) were prepared by density gradient centrifugation using Lymphoprep^TM (Axis-Shield PoC AS, Oslo, Norway) according to previously reported protocols [11,12]. CD4⁺ T cells were isolated from PBMCs using a MACS CD4⁺ T cell isolation kit II (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions, and CD4⁺CD25⁺CD127^/low T cells were isolated as described previously [12].

2.2.2. Surface Marker Analysis in CD4⁺CD25⁺FOXP3⁺ T Cells

Purified CD4⁺ T cells (1 × 10⁶ cells) were suspended in 1 mL fixation solution (5% paraformaldehyde and 0.5% Tween 20 in phosphate buffered saline [PBS]) and stored overnight at 4 °C. Intracellular FOXP3 staining was performed by anti-FOXP3 monoclonal antibodies (mAbs) conjugated to different fluorochromes, as described previously [26]. To analyse surface antigen expression, staining with Alexa Fluor^® 488-FOXP3 mAb was followed by staining for one of the following dual staining paradigms: PE-labelled CD25 (M-A251) plus PC5-labelled CD127, PC5-labelled CD25 (B1.49.9) plus PE-labelled CD45RO (UCHL1), or PC5-labelled CD25 plus PE-labelled CD45RA (HI100). When unlabelled anti-FOXP3 (259D) and biotin-conjugated anti-CD127 (eBiRD5) mAbs (all antibodies were from eBioscience, Inc., San Diego, CA, USA) were used as primary antibodies, cells were incubated with Alexa Fluor^® 488- or PC5-streptavidin-labelled secondary antibodies, respectively. The cells were incubated with either non-conjugated or fluorochrome-conjugated antibodies for 15 min at 4 °C. Alexa Fluor^® 488-secondary antibody, PE-CD25, PC5-streptavidin, PE-CD45RO, and PE-CD45RA antibodies were obtained from BD Biosciences (Franklin Lakes, NJ, USA) and PC5-CD25 and streptavidin-PC5 antibodies were obtained from Beckman Coulter (Pasadena, CA, USA). The samples were suspended in 350 μL fluorescence-activated cell sorting (FACS) buffer (PBS, 5% fetal bovine serum [FBS], 2 mM EDTA and 0.1% sodium azide) and were analysed by flow cytometry using EPICS XL (Beckman Coulter). The data were analysed by FlowJo software (TreeStar, Ashland, OR, USA). Gating was performed on cells that were highly expressing CD25 (CD25^high) to increase T_reg purity, as the intracellular phosflow labeling was not compatible with FOXP3 co-staining. In the other analyses, CD25 positive cells including both CD25^low and CD25^high were gated as CD25⁺.

2.3. Phosphorylation of ERK1/2 and p38 MAPK

Activation of cellular signaling in CD4⁺CD25^high T cells in response to oxidative stress was analysed using BD Phosflow technology (BD Biosciences). Briefly, 3 × 10⁵ PBMCs were suspended in 15 μL of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered saline (107 mM NaCl, 6 mM KCl, 1.2 mM MgSO₄, 2 mM CaCl₂, 1.2 mM KH₂PO₄, 11.5 mM glucose, and 20 mM HEPES adjusted to pH 7.4 with NaOH) containing 0.1% BSA and incubated with H₂O₂ at increasing concentrations from 10 μM to 10 mM for 10 min at 37 °C with agitation at 350 rpm using a reciprocal shaker. After oxidative stress induction, the reaction was stopped by fixing the cells with 250 μL of Cytofix/Cytoperm solution (BD Biosciences) for 10 min at 37 °C. Cells were washed twice with Perm/Wash buffer (BD Biosciences) and resuspended in 50 μL of Perm/Wash buffer. For the analysis of ERK1/2 or p38 MAPK phosphorylation in CD4⁺CD25^high T cells, the following fluorescence labelling antibodies were added at 6 μL each and incubated for 60 min at room temperature in the dark: PC5-CD4 (13B8.2; Beckman Coulter), PE-CD25 (M-A251; BD Biosciences), and Alexa488-pERK1/2 (T202/Y204) (612592; BD Biosciences) or Alexa 488-pp38 MAPK (T180/Y182) (612594; BD Biosciences). After washing with the Perm/Wash buffer, the cells were resuspended in 100 μL of FACS buffer and analysed by flow cytometry.

2.4. Measurement of Intracellular Ca²⁺ Influx

Changes in intracellular Ca²⁺ influx [Ca²⁺]_i were measured using the cell-permeable Fura-2 AM fluorescent dye, as described previously [12,27]. Images of Fura-2-loaded cells were analysed using a video image analyser (Meta Fulora; Nippon Ropper, Tokyo, Japan). Cytosolic Ca²⁺ concentrations were assessed by exciting the cells at 340 and 380 nm using the dual-wavelength excitation method and measuring fluorescence at 510 nm. We have previously shown that Ca²⁺ responses were divided into two categories based on the ratio of peak fluorescence (340/380): poor (<0.1) and robust (>0.1) [12].

2.5. Microarray Analysis

RNA was isolated from cells using RNAiso Plus (Takara Bio. Inc., Shiga, Japan). Microarray analysis was performed using the 3D-Gene human oligo chip 25k (TORAY Industries, Tokyo, Japan). RNA sample quality was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and Nanodrop^® (Thermo Fisher Scientific, Waltham, MA, USA). RNA amplification and Cy5-labeling were performed using Ambion Amino Allyl aRNA (Thermo Fisher Scientific) and Amersham Cy5 mono-reactive dye (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA), respectively. The Cy5-labeled amplified RNA samples (1 μg per sample) were hybridized at 37 °C for 16 h and scanned using the 3D-Gene Scanner 3000 (TORAY). After subtracting background signal from raw data on each chip, the signal of each gene was normalized by the global normalisation method where the median of the detected signal intensity was adjusted to 25.

Microarray samples were selected and prepared as mentioned below. We have previously generated Jurkat Tet-On^® cells with Dox-inducible FOXP3 protein expression: 5G1 cells are control cells, and F2A9 cells are derived from a Jurkat Tet-On^® cell line with Dox-inducible FOXP3 [12]. F2A9 cells that were induced with Dox for two days for FOXP3 expression (FOXP3 2-day) demonstrated low [Ca²⁺]_i in response to TCR stimulation, similar to that observed in CD4⁺CD25⁺ T cells from subjects without asthma. However, Ca²⁺ responsiveness in F2A9 cells induced with Dox for 5 days (FOXP3 5-day) was similar to that observed in cells from asthmatic subjects [12]. Samples were named Control 2-day, Control 5-day, FOXP3 2-day, and FOXP3 5-day.

Microarray data were analysed for antioxidant gene expression as illustrated by a HeatMap (Supplementary Figure S1). We focused on genes with increased expression in FOXP3 2-day compared with control 2-day, rather than 5-day versus FOXP3 5-day because of the FOXP3 2-day tolerability to oxidative stress. Since FOXP3 5-day is a model cell for asthma T_regs, the cells are considered more sensitive to oxidative stress than FOXP3 2-day (non-asthma T_regs). We selected the genes that are able to scavenge reactive oxygen species (ROS) directly for further analyses.

2.6. Real-Time Polymerase Chain Reaction

RNA extraction, reverse transcription, and real-time polymerase chain reaction (RT-PCR) were performed as described previously [12]. Peroxiredoxin-2 (Hs99999903_m1) were measured using specific TaqMan^® probe primer sets (Life Technologies, Carlsbad, CA, USA), and the mRNA expression of peroxiredoxin-2 (Hs00853603_s1_M), -3 (Hs00428953_g1_M), -4 (Hs01056076_m1_M) and β-actin (NM_005809.5), -3 (NM_014098.3), -4 (NM_006406.1), and β-actin (NM_001101) were quantified using a StepOne^TM Real-Time PCR system (Life Technologies). The expression of each gene was normalized to β-actin expression.

2.7. Quantification of Glutathione

Glutathione content was measured by the GSH-Glo^TM glutathione assay (Promega, Madison, WI, USA) according to the manufacturer’s instructions. Furthermore, 4 × 10³ Jurkat cells were suspended in 50 μL of PBS and mixed with 50 μL of 2 × GSH-Glo reagent. Cells were incubated for 30 min at room temperature. After the addition of 100 μL luciferin detection reagent, cells were incubated for 15 min at room temperature. The luminescence was measured at 23 °C with a Tecan Infinite^® 200 PRO multimode microplate reader.

2.8. Measurement of Caspase Activity

In total, 1 × 10⁶ Jurkat cells were treated with either PBS or 100 μM H₂O₂ in 5 mL of RPMI 1640 media containing 0.1% BSA for 4 h in a CO₂ incubator. The cells were washed twice with PBS, and the supernatants were removed. Caspase activity was measured by the fluorimetric SensoLyte^® 520 generic caspase assay (AnaSpec, Fremont, CA, USA) according to the manufacturer’s instructions. Briefly, cells were resuspended in 300 μL of RPMI 1640 media containing 0.1% BSA in a 2 mL tube and incubated with 10 μL of FAM-VAD FMK working solution for 1 h in a CO₂ incubator. Fluorescence intensity was measured at the excitation wavelength of 490 nm and emission wavelength of 520 nm with Tecan Infinite^® 200 PRO multimode microplate reader.

2.9. Statistical Analysis

Data were expressed as mean ± standard deviation (SD) unless specified otherwise. Multiple comparisons were calculated by analysis of variance (ANOVA) with a Tukey–Kramer post-hoc test with data comparison among all groups. Data from two groups were analysed by Student’s t test. All statistical tests were performed using JMP Pro version 12.0.1 (SAS Institute, Cary, NC, USA).

3. Results

3.1. Phenotypic Switching of CD4⁺CD25⁺FOXP3⁺ T_reg Cells from CD45RA⁺ to CD45RO⁺ during Development in Early Childhood

The surface marker expression of CD4⁺ T cells in paediatric subjects with or without allergy was determined by flow cytometric analysis. As shown in Figure 1a in a representative flow histogram, the majority of CD4⁺CD25⁺FOXP3⁺ T cells from the control without allergy and subject with allergy (subject with allergy no. 1 in Figure 1a) expressed comparably low or no CD127 (CD127^−/low). In addition, as shown in representative cases, the percentage of CD4⁺CD25⁺FOXP3⁺ T cells that were CD45RO⁺ was lower in the 1-year-old control and the 1-year-old allergic subject no. 2 that had both food allergy and atopic dermatitis than that in the allergic subject no. 3, an 9.7-year-old child with paediatric allergic asthma (Figure 1b). In agreement with previous studies, FOXP3 expression was much higher in the CD45RO⁺ population than in the CD45RA⁺ population (Figure 1c) [11]. Furthermore, CD45RO expression on CD4⁺CD25⁺FOXP3⁺ T cells was affected by age. Our analysis demonstrated decreases in CD45RA expression with reciprocal increases in the expression of CD45RO beginning at the age of 4 years (Figure 1d,e). However, the percentage of CD45RO population in CD4⁺CD25⁺FOXP3⁺ T cells in the paediatric cohort did not reach the level reported in adults, which is 88.5 ± 7.5% in CD4⁺CD25^high T cells and approximately 99% in CD4⁺CD25^{very high} T cells [11,28].

3.2. High Tolerance of CD4⁺CD25^high T_reg Cells from Adults without Asthma to H₂O₂-Mediated Oxidative Stress

Activation of ERK1/2 signalling by its phosphorylation (pERK1/2) in T_reg cells has been shown to be insensitive to T-cell receptor (TCR) stimulation and oxidative stress [29,30], whereas phosphorylation of p38 MAPK (pp38 MAPK) plays an important role in T cell activation [31,32]. Therefore, we analysed pERK1/2 and pp38 MAPK levels in H₂O₂-exposed T_regs from subjects with allergy. Our results indicated that H₂O₂ resulted in a dose-dependent phosphorylation of p38 MAPK in CD4⁺CD25^high T_regs from paediatric and adult subjects without allergy (Figure 2a). Further, T_regs from asthmatic adult subjects were more susceptible to p38 MAPK phosphorylation upon exposure to 50 μM H₂O₂ than those from subjects without asthma. The responses of CD4⁺CD25^high T_reg cells from paediatric subjects with or without allergy to H₂O₂ were similar to those observed in the same cell population from adult subjects with allergy (Figure 2b,c). In contrast, ERK1/2 phosphorylation in CD4⁺CD25^high T cells from adult subjects without asthma was observed only at high dose H₂O₂ (10 mM) treatment (Figure 3a). Measurement of [Ca²⁺]_i results in these adult subjects showed that pERK1/2 accumulation induced by 10 mM H₂O₂ corresponded with increased influx of Ca²⁺, indicating the characteristic anergic response of these T_reg cells [12] (Figure 3b–d). CD4⁺CD25^high T_reg cells from subjects with increased Ca²⁺ response showed increased pERK1/2 expression, whereas cells with poor Ca²⁺ response were from subjects without asthma. However, the change in pERK1/2 expression in paediatric CD4⁺CD25^high T_regs cells was different compared with that observed in adults. ERK1/2 phosphorylation was observed at lower doses of H₂O₂ in CD4⁺CD25^high T_reg cells from paediatric subjects, and occurred more frequently, compared with adults. In addition, ERK1/2 phosphorylation was comparable between paediatric subjects with and without allergy (Figure 3b,c).

3.3. Age-Dependent Sensitivity of Jurkat Tet-On^® FOXP3 Cells to H₂O₂ Exposure In Vitro

Jurkat cells inducibly overexpressing FOXP3 for 2 days (FOXP3 2-day cells) are similar to CD4⁺CD25⁺CD127^−/low T cells from subjects without asthma and FOXP3 5-day cells are similar to T_regs from asthmatic subjects. Sensitivity to oxidative stress was evaluated by H₂O₂-induced caspase activity, intracellular glutathione content, and microarray analysis. The glutathione content of FOXP3 2-day cells was similar to that measured in control cells; however, it was decreased in FOXP3 5-day cells (Figure 4a). H₂O₂-induced caspase activation in FOXP3 2-day cells was lesser than that observed in control cells treated with H₂O₂; however, caspase activation in FOXP3 5-day cells was restored to the level measured in control cells (Figure 4b). Microarray analysis revealed that peroxiredoxin (PRDX)-2, -3, and -4 were among the antioxidant genes that were increased distinctly in FOXP3 2-day cells, but not in control or FOXP3 5-day cells (Table 2). The results obtained by microarray were confirmed by measurement of the mRNA expression of these three genes in T_reg cells isolated from peripheral blood of adult subjects with or without asthma (Figure 4c).

4. Discussion

CD45RO, as a T_reg surface marker, is considered an indicator of T_reg maturity. CD4⁺FOXP3^lowCD45RA⁺ T cells are naive resting T_reg cells, whereas CD4⁺FOXP3^highCD45RA⁻ T cells, like CD4⁺FOXP3^highCD45RO⁺ T cells, constitute mature activated T_reg cells [23]. Both T_reg subtypes have a suppressive capacity in vitro, whereas phenotypically immature T_regs have the capacity to differentiate into phenotypically mature T_reg cells in vitro and in vivo. Previous reports indicated that phenotypically immature T_regs predominated in cord blood and in newborns [21,33]. Our data suggested that CD4⁺FOXP3^lowCD45RA⁺ T cells were dominant in peripheral blood before the age of 4 years, and that T_regs subsequently switched from an immature phenotype to a mature phenotype. Maternal antigen exposure is a crucial factor in phenotypic switching of CD45 T cell isoforms from pregnancy to infancy. Thereafter, phenotypic switching persists on further extrinsic antigen exposure that continues until adolescence. Similarly, T_reg cells have been suggested to undergo this type of conversion from immature to mature phenotypes in adults.

Several studies implicate low FOXP3 protein expression as a mechanism for abnormal T_reg function [6,7,8,9]. When we compared the characteristics of T_reg cells between paediatric and adult subjects with or without allergy, we observed that the phosphorylation of cellular signalling molecules ERK1/2 and p38 MAPK in T cells were increased by exposure to H₂O₂. Recently, T_reg cells were reported to have a high oxidative stress buffering capacity via increased secretion of thioredoxin-1 (TXN) [24]. When we examined T_reg cells with functional assays, we specifically observed that the T_reg cells from adults without asthma had attenuated pERK1/2 accumulation in response to H₂O₂ treatment, whereas the T_reg cells from adults with asthma were able to increase pERK1/2 under the same conditions. In addition, pERK1/2 was associated with robust Ca²⁺ influx in response to TCR stimulation in T_reg cells from adults with asthma. Previous reports demonstrated that the Ca²⁺ response of T_reg cells from children was correlated with the severity of asthma [11] and that of T_reg cells from adults was correlated with functional abnormalities of this cell type [12]. The Ca²⁺ response of adult T_reg cells can be divided into poor and robust response. Our findings indicated that robust pERK1/2 accumulation in T_reg cells from adults with asthma correlated with robust Ca²⁺ responses. Several studies suggested that ERK1/2 phosphorylation may occur following intracellular Ca²⁺ influx induced by exposure to H₂O₂ [27,34] and imply that robust Ca²⁺ response in T_reg cells may stimulate ERK1/2 phosphorylation. The increases in pERK1/2 and pp38 MAPK expression in response to oxidative stress were more robust in T_reg cells from paediatric subjects than those from adult subjects. These results imply that immature CD45RA⁺ T_reg cells were more sensitive to oxidative stress than CD45RO⁺ mature T_reg cells.

Our caspase activity studies showed that FOXP3 2-day cells were more tolerant to H₂O₂ than control cells, despite comparable glutathione content in both cell types, suggesting a distinct antioxidant response against oxidative stress. Microarray analysis revealed that peroxiredoxins, but not thioredoxin-1, were involved in tolerance to oxidative stress in our model system. In agreement with the results of microarray analysis of Tet-On^® Jurkat cells, mRNA expression of peroxiredoxin (PRDX)-2, -3, and -4 in T_reg cells from adults with asthma was decreased compared with T_reg cells from adults without asthma. Similarly, in Th17 cells, peroxiredoxin-2 was suggested to function as an antioxidant during chronic inflammatory processes [35]. We speculate that T_reg cells from adults with asthma were sensitized by oxidative stress with regard to inflammation; thus, the activation of ERK1/2 signalling was easily transduced. Chronic exposure to oxidative stress has been suggested to lead to death of T_reg cells in adults with asthma, compared with those in adults without asthma. The T_reg cells from paediatric subjects were sensitive to H₂O₂ exposure and Ca²⁺-responsive to TCR stimulation, irrespective of the presence of allergies in subjects [11], suggesting that T_reg cells from paediatric subjects were activated easily and were more susceptible to cell death. In summary, the phenotypic switching of T_reg cells were analysed based on the expression of CD45 isoforms during development. The high percentage of CD45RA⁺ T_reg cells in paediatric subjects may be reflected in their increased ERK1/2 signalling in response to H₂O₂ exposure. In contrast, T_regs from adults without asthma, most of which expressed CD45RO⁺, were tolerant to H₂O₂ exposure, whereas T_reg cells from adults with asthma were not. Increased tolerance of non-asthmatic adult T_reg cells may be attributable to intact upregulation of peroxiredoxins. Finally, assessment of MAPK phosphorylation in response to oxidative stress by flow cytometry is a simple and effective method for the evaluation of T_reg cell function in adults with asthma.

5. Conclusions

Developmental T_reg phenotypic switching occurs in early childhood, which may be a consequence of exposure to extrinsic antigens such as bacteria and viruses. The differential T_reg sensitivity to oxidative stress observed in children and adults was likely dependent on phenotypic CD45 isoform switching. Increased sensitivity of T_reg cells from adults with asthma to H₂O₂ resulted from a reduction of peroxiredoxin-2, -3, and -4 and increased pERK1/2 via impaired Ca²⁺ response in these cells.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/biomedicines9060616/s1: Figure S1: Microarray data.

Author Contributions

Conceptualization, Y.Y. and T.N.; methodology, Y.Y., T.N., R.T. and Y.N. (Yoichi Negishi).; validation, Y.Y.; formal analysis, Y.Y.; investigation, Y.Y., T.N., R.T., M.N. and A.H.; resources, Y.Y., Y.N. (Yoichi Negishi) and Y.N. (Yasuko Nakano).; data curation, Y.Y. and A.H.; writing—original draft preparation, Y.Y.; writing—review and editing, T.N., R.T., Y.N. (Yoichi Negishi). and Y.N. (Yasuko Nakano); visualization, Y.Y. and R.T.; supervision, Y.Y., Y.N. (Yoichi Negishi) and Y.N. (Yasuko Nakano); project administration, Y.Y.; funding acquisition, T.N., Y.N. (Yoichi Negishi) and Y.N. (Yasuko Nakano). All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#24591471 and #15K09557).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Showa University Medical Ethics Committee (protocol number 310 for paediatric subjects, protocol number 2002022 for adult subjects) and the Tokyo Metropolitan Ebara Hospital Trust local research and ethics committee.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

Data are contained within the article or Supplementary Materials.

Acknowledgments

We thank Akiko Wakagi, who is a student in the Showa University School of Pharmacy, for technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

Akdis, M.; Verhagen, J.; Taylor, A.; Karamloo, F.; Karagiannidis, C.; Crameri, R.; Thunberg, S.; Deniz, G.; Valenta, R.; Fiebig, H.; et al. Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-Specific T Regulatory 1 and T Helper 2 Cells. J. Exp. Med. 2004, 199, 1567–1575. [Google Scholar] [CrossRef] [PubMed]
Jaffar, Z.; Ferrini, M.E.; Girtsman, T.A.; Roberts, K. Antigen-specific T_reg Regulate Th17-mediated Lung Neutrophilic Inflammation, B-cell Recruitment and Polymeric IgA and IgM Levels in the Airways. Eur. J. Immunol. 2009, 39, 3307–3314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T.; Sakaguchi, S. CTLA-4 Control over Foxp3+ Regulatory T Cell Function. Science 2008, 322, 271–275. [Google Scholar] [CrossRef]
Strickland, D.H.; Holt, P.G. T Regulatory Cells in Childhood Asthma. Trends Immunol. 2011, 32, 420–427. [Google Scholar] [CrossRef]
Hamasaki, Y.; Kohno, Y.; Ebisawa, M.; Kondo, N.; Nishima, S.; Nishimuta, T.; Morikawa, A. Japanese Guideline for Childhood Asthma 2014. Allergol. Int. 2014, 63, 335–356. [Google Scholar] [CrossRef] [Green Version]
Hartl, D.; Koller, B.; Mehlhorn, A.T.; Reinhardt, D.; Nicolai, T.; Schendel, D.J.; Griese, M.; Krauss-Etschmann, S. Quantitative and Functional Impairment of Pulmonary CD4⁺CD25^hi Regulatory T Cells in Pediatric Asthma. J. Allergy Clin. Immun. 2007, 119, 1258–1266. [Google Scholar] [CrossRef]
Provoost, S.; Maes, T.; Durme, Y.M.V.; Gevaert, P.; Bachert, C.; Schmidt-Weber, C.B.; Brusselle, G.G.; Joos, G.F.; Tournoy, K.G. Decreased FOXP3 Protein Expression in Patients with Asthma. Allergy 2009, 64, 1539–1546. [Google Scholar] [CrossRef] [PubMed]
Lin, Y.-L.; Shieh, C.-C.; Wang, J.-Y. The Functional Insufficiency of Human CD4⁺CD25^high T-regulatory Cells in Allergic Asthma Is Subjected to TNF-α Modulation. Allergy 2008, 63, 67–74. [Google Scholar] [CrossRef] [PubMed]
Vale-Pereira, S.; Todo-Bom, A.; Geraldes, L.; Schmidt-Weber, C.; Akdis, C.A.; Mota-Pinto, A. FoxP3, GATA-3 and T-bet Expression in Elderly Asthma. Clin. Exp. Allergy 2011, 41, 490–496. [Google Scholar] [CrossRef]
Ling, E.M.; Smith, T.; Nguyen, X.D.; Pridgeon, C.; Dallman, M.; Arbery, J.; Carr, V.A.; Robinson, D.S. Relation of CD4⁺CD25⁺ Regulatory T-Cell Suppression of Allergen-Driven T-Cell Activation to Atopic Status and Expression of Allergic Disease. Lancet 2004, 363, 608–615. [Google Scholar] [CrossRef]
Yamamoto, Y.; Negoro, T.; Hoshi, A.; Wakagi, A.; Shimizu, S.; Banham, A.H.; Ishii, M.; Akiyama, H.; Kiuchi, Y.; Sunaga, S.; et al. Impaired Ca²⁺ Regulation of CD4⁺CD25⁺ Regulatory T Cells from Pediatric Asthma. Int. Arch. Allergy Immunol. 2011, 156, 148–158. [Google Scholar] [CrossRef]
Negoro, T.; Shimizu, S.; Narushima, M.; Banham, A.H.; Wakabayashi, H.; Takayanagi, R.; Hagiwara, T.; Roncador, G.; Osabe, T.; Yanai, T.; et al. Elevated Receptor for Activated C Kinase 1 Expression Is Involved in Intracellular Ca²⁺ Influx and Potentially Associated with Compromised Regulatory T Cell Function in Patients with Asthma. Clin. Exp. Allergy 2014, 44, 1154–1169. [Google Scholar] [CrossRef]
Shi, H.-Z.; Li, S.; Xie, Z.-F.; Qin, X.-J.; Qin, X.; Zhong, X.-N. Regulatory CD4⁺CD25⁺ T Lymphocytes in Peripheral Blood from Patients with Atopic Asthma. Clin. Immunol. 2004, 113, 172–178. [Google Scholar] [CrossRef] [PubMed]
Smyth, L.J.C.; Eustace, A.; Kolsum, U.; Blaikely, J.; Singh, D. Increased Airway T Regulatory Cells in Asthmatic Subjects. Chest 2010, 138, 905–912. [Google Scholar] [CrossRef]
Thunberg, S.; Gafvelin, G.; Nord, M.; Grönneberg, R.; Grunewald, J.; Eklund, A.; Hage, M.V. Allergen Provocation Increases TH2-cytokines and FOXP3 Expression in the Asthmatic Lung. Allergy 2010, 65, 311–318. [Google Scholar] [CrossRef] [PubMed]
Karagiannidis, C.; Akdis, M.; Holopainen, P.; Woolley, N.J.; Hense, G.; Rückert, B.; Mantel, P.-Y.; Menz, G.; Akdis, C.A.; Blaser, K.; et al. Glucocorticoids Upregulate FOXP3 Expression and Regulatory T Cells in Asthma. J. Allergy Clin. Immun. 2004, 114, 1425–1433. [Google Scholar] [CrossRef] [PubMed]
Prado, C.; Gómez, J.; López, P.; de Paz, B.; Gutiérrez, C.; Suárez, A. Dexamethasone Upregulates FOXP3 Expression without Increasing Regulatory Activity. Immunobiology 2011, 216, 386–392. [Google Scholar] [CrossRef] [PubMed]
Robinson, D.S. Regulatory T Cells and Asthma. Clin. Exp. Allergy 2009, 39, 1314–1323. [Google Scholar] [CrossRef]
Ray, A.; Khare, A.; Krishnamoorthy, N.; Qi, Z.; Ray, P. Regulatory T Cells in Many Flavors Control Asthma. Mucosal. Immunol. 2010, 3, 216–229. [Google Scholar] [CrossRef]
Palomares, O.; Yaman, G.; Azkur, A.K.; Akkoc, T.; Akdis, M.; Akdis, C.A. Role of T_reg in Immune Regulation of Allergic Diseases. Eur. J. Immunol. 2010, 40, 1232–1240. [Google Scholar] [CrossRef]
Thornton, C.A.; Upham, J.W.; Wikström, M.E.; Holt, B.J.; White, G.P.; Sharp, M.J.; Sly, P.D.; Holt, P.G. Functional Maturation of CD4⁺CD25⁺CTLA4⁺CD45RA⁺ T Regulatory Cells in Human Neonatal T Cell Responses to Environmental Antigens/Allergens. J. Immunol. 2004, 173, 3084–3092. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Valmori, D.; Merlo, A.; Souleimanian, N.E.; Hesdorffer, C.S.; Ayyoub, M. A Peripheral Circulating Compartment of Natural Naive CD4⁺ T_regs. J. Clin. Investig. 2005, 115, 1953–1962. [Google Scholar] [CrossRef]
Miyara, M.; Yoshioka, Y.; Kitoh, A.; Shima, T.; Wing, K.; Niwa, A.; Parizot, C.; Taflin, C.; Heike, T.; Valeyre, D.; et al. Functional Delineation and Differentiation Dynamics of Human CD4⁺ T Cells Expressing the FoxP3 Transcription Factor. Immunity 2009, 30, 899–911. [Google Scholar] [CrossRef] [Green Version]
Mougiakakos, D.; Johansson, C.C.; Jitschin, R.; Böttcher, M.; Kiessling, R. Increased Thioredoxin-1 Production in Human Naturally Occurring Regulatory T Cells Confers Enhanced Tolerance to Oxidative Stress. Blood 2011, 117, 857–861. [Google Scholar] [CrossRef] [Green Version]
Baty, J.W.; Hampton, M.B.; Winterbourn, C.C. Proteomic Detection of Hydrogen Peroxide-Sensitive Thiol Proteins in Jurkat Cells. Biochem. J. 2005, 389, 785–795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Roncador, G.; Brown, P.J.; Maestre, L.; Hue, S.; Martínez-Torrecuadrada, J.L.; Ling, K.; Pratap, S.; Toms, C.; Fox, B.C.; Cerundolo, V.; et al. Analysis of FOXP3 Protein Expression in Human CD4⁺CD25⁺ Regulatory T Cells at the Single-cell Level. Eur. J. Immunol. 2005, 35, 1681–1691. [Google Scholar] [CrossRef] [PubMed]
Yamamoto, S.; Shimizu, S.; Kiyonaka, S.; Takahashi, N.; Wajima, T.; Hara, Y.; Negoro, T.; Hiroi, T.; Kiuchi, Y.; Okada, T.; et al. TRPM2-Mediated Ca²⁺ Influx Induces Chemokine Production in Monocytes That Aggravates Inflammatory Neutrophil Infiltration. Nat. Med. 2008, 14, 738–747. [Google Scholar] [CrossRef] [PubMed]
Baecher-Allan, C.; Brown, J.A.; Freeman, G.J.; Hafler, D.A. CD4⁺CD25^high Regulatory Cells in Human Peripheral Blood. J. Immunol. 2001, 167, 1245–1253. [Google Scholar] [CrossRef] [Green Version]
Chang, C.-F.; D’Souza, W.N.; Ch’en, I.L.; Pages, G.; Pouyssegur, J.; Hedrick, S.M. Polar Opposites: Erk Direction of CD4 T Cell Subsets. J. Immunol. 2012, 189, 721–731. [Google Scholar] [CrossRef] [Green Version]
Liu, H.; Yao, S.; Dann, S.M.; Qin, H.; Elson, C.O.; Cong, Y. ERK Differentially Regulates Th17- and T_reg-cell Development and Contributes to the Pathogenesis of Colitis. Eur. J. Immunol. 2013, 43, 1716–1726. [Google Scholar] [CrossRef] [PubMed]
Dodeller, F.; Skapenko, A.; Kalden, J.R.; Lipsky, P.E.; Schulze-Koops, H. The P38 Mitogen-activated Protein Kinase Regulates Effector Functions of Primary Human CD4 T Cells. Eur. J. Immunol. 2005, 35, 3631–3642. [Google Scholar] [CrossRef] [PubMed]
Ebel, M.E.; Awe, O.; Kaplan, M.H.; Kansas, G.S. Diverse Inflammatory Cytokines Induce Selectin Ligand Expression on Murine CD4 T Cells via P38α MAPK. J. Immunol. 2015, 194, 5781–5788. [Google Scholar] [CrossRef] [Green Version]
Ly, N.P.; Ruiz-Perez, B.; McLoughlin, R.M.; Visness, C.M.; Wallace, P.K.; Cruikshank, W.W.; Tzianabos, A.O.; O’Connor, G.T.; Gold, D.R.; Gern, J.E. Characterization of Regulatory T Cells in Urban Newborns. Clin. Mol. Allergy 2009, 7, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Lysechko, T.L.; Cheung, S.M.S.; Ostergaard, H.L. Regulation of the Tyrosine Kinase Pyk2 by Calcium Is through Production of Reactive Oxygen Species in Cytotoxic T Lymphocytes*. J. Biol. Chem. 2010, 285, 31174–31184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Szabó-Taylor, K.É.; Eggleton, P.; Turner, C.A.L.; Faro, M.L.L.; Tarr, J.M.; Tóth, S.; Whiteman, M.; Haigh, R.C.; Littlechild, J.A.; Winyard, P.G. Lymphocytes from Rheumatoid Arthritis Patients Have Elevated Levels of Intracellular Peroxiredoxin 2, and a Greater Frequency of Cells with Exofacial Peroxiredoxin 2, Compared with Healthy Human Lymphocytes. Int. J. Biochem. Cell Biol. 2012, 44, 1223–1231. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Figure 1. Flow cytometric surface marker analysis of CD4⁺ T cells isolated from paediatric PBMCs are shown from representative cases. In total, 1 × 10⁶ CD4⁺ cells were stained with Alexa 488-FOXP3, PE-CD25, and PC5-CD127 (a), or with Alexa 488-FOXP3, PC5-CD25, and PE-CD45RO (b). Representative flow histograms are shown. (c) The cells were stained with Alexa 488-FOXP3, PC5-CD25, and PE-CD45RO or CD45RA. Representative flow histograms are shown. (d) Results from individual paediatric subjects are plotted by bar graph. (e) Data from (d) were combined into 4 groups by age, and the difference was statistically analysed. All histograms were gated with CD25 because of the analysis of purified CD4⁺ T cells.

Figure 2. Flow cytometric measurement of p38 MAPK phosphorylation in response to H₂O₂ exposure in CD4⁺CD25^high T cells from paediatric and adult subjects. 3 × 10⁵ PBMCs were incubated for 10 min and stained with PC5-CD4, PE-CD25, and Alexa 488-pp38 MAPK. Representative flow histograms from paediatric subjects without allergy and adult subjects without asthma are shown (a). Phosphorylation of p38 MAPK in cells exposed to 50 μM H₂O₂ or vehicle were compared between paediatric subjects with and without allergy and adult subjects with or without asthma. Representative flow histograms (b) and average percentage of pp38 MAPK-positive cells are plotted by bar graphs (c). Gating was performed on cells highly expressing CD25 antigen.

Figure 3. Flow cytometric measurement of ERK1/2 phosphorylation by H₂O₂ exposure in CD4⁺CD25^high T cells from paediatric subjects without allergy and adult subjects without asthma that were exposed to 10 mM H₂O₂ were stained with PC5-CD4, PE-CD25, and Alexa 488-pERK1/2. The representative flow histograms are shown in (a). The typical patterns of pERK1/2 expression among all child subject groups are shown in (b). The average percentage of pERK1/2- positive cells in all adult subject groups were plotted by bar graphs, and asthma subjects were further divided into two groups by Ca²⁺ response (c). Typical patterns (poor response and robust response) of Ca²⁺ response are depicted in (d). Gating was performed on cells highly expressing CD25 antigen.

Figure 4. Assessment of the sensitivity of FOXP3⁺ cells to oxidative stress. The measurement of antioxidant levels and caspase activity in response to H₂O₂ were compared with those in control cells. Glutathione content in FOXP3 2-day and FOXP3 5-day cells were compared with control cells (a). Caspase activity in response in the abovementioned cells exposed to 100 μM H₂O₂ for 4 h were measured (b). mRNA expression of peroxiredoxins in CD4⁺CD25⁺CD127^−/low T cells were quantified by real-time PCR (c).

Table 1. Clinical characteristics of study subjects.

	Child		Adult
	Allergy	Non-Allergy	Asthma	Non-Asthma
	(n = 38)	(n = 11)	(n = 10)	(n = 6)
Age	4.7 ± 3.5	4.0 ± 2.6	51.1 ± 20.1	29.3 ± 6.8
Gender (male/female)	28/10	6/5	6/4	4/2
Type
Atopic	38		8
Nonatopic	0		2
Asthma severity
Step 1	2
Step 2	9		3
Step 3	11		7
Step 4	4
Food allergy	15 (3) *¹
Atopic dermatitis	13 (7) *²
Allergic rhinitis	2
Dose of ICS
CFC-BDP mg/day	183 (0–800)		492 (400–1600)
Smoking
Nonsmoker			7	6
Current smoker			3	0

^*1, ^*2: The number in parentheses indicates those further complicated by asthma.

Table 2. Microarray analysis.

		Control		FOXP3		Ratio
Symbol	Description	2-Day	5-Day	2-Day	5-Day	(FOXP3/Control 2-Day)
PXDN	Peroxidasin homolog Precursor (EC 1.11.1.7)(Vascular peroxidase 1)(Melanoma-associated antigen MG50)(p53-responsive gene 2 protein) [Source:UniProtKB/Swiss-Prot;Acc:Q92626]	69	50	230	184	3.33
TXNIP	Thioredoxin-interacting protein (Vitamin D3 up-regulated protein 1)(Thioredoxin-binding protein 2) [Source:UniProtKB/Swiss-Prot;Acc:Q9H3M7]	55	29	140	54	2.55
PRDX4	Peroxiredoxin-4 (EC 1.11.1.15)(Prx-IV)(Thioredoxin peroxidase AO372)(Thioredoxin- dependent peroxide reductase A0372)(Antioxidant enzyme AOE372)(AOE37-2) [Source:UniProtKB/Swiss-Prot;Acc:Q13162]	392	392	621	459	1.58
GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial Precursor (PHGPx)(EC 1.11.1.12)(GPX-4) [Source:UniProtKB/Swiss-Prot;Acc:P36969]	1444	1151	2233	1832	1.55
SRXN1	Sulfiredoxin-1 (EC 1.8.98.2) [Source:UniProtKB/Swiss-Prot;Acc:Q9BYN0]	127	93	181	108	1.43
PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial Precursor (EC 1.11.1.15)(Peroxiredoxin-3)(PRX III)(Antioxidant protein 1)(AOP-1)(Protein MER5 homolog)(HBC189) [Source:UniProtKB/Swiss-Prot;Acc:P30048]	550	555	767	550	1.39
PRDX2	Peroxiredoxin-2 (EC 1.11.1.15)(Thioredoxin peroxidase 1)(Thioredoxin-dependent peroxide reductase 1)(Thiol-specific antioxidant protein)(TSA)(PRP)(Natural killer cell-enhancing factor B)(NKEF-B) [Source:UniProtKB/Swiss-Prot;Acc:P32119]	1972	1919	2378	1756	1.21
PRDX5	Peroxiredoxin-5, mitochondrial Precursor (EC 1.11.1.15)(Prx-V)(Peroxisomal antioxidant enzyme)(PLP)(Thioredoxin reductase)(Thioredoxin peroxidase PMP20)(Antioxidant enzyme B166)(AOEB166)(TPx type VI)(Liver tissue 2D-page spot 71B)(Alu corepressor 1) [Source:UniProtKB/Swiss-Prot;Acc:P30044]	1571	1910	1529	1978	0.97
TXN	Thioredoxin (Trx)(ATL-derivedfactor)(ADF)(Surface-associated sulphydryl protein)(SASP) [Source:UniProtKB/Swiss- Prot;Acc:P10599]	3510	3689	2338	1850	0.67
PRDX1	Peroxiredoxin-1 (EC 1.11.1.15)(Thioredoxin peroxidase 2)(Thioredoxin-dependent peroxide reductase 2)(Proliferation-associated gene protein)(PAG)(Natural killer cell-enhancing factor A)(NKEF-A) [Source:UniProtKB/Swiss- Prot;Acc:Q06830]	3861	3068	1303	1138	0.34

Shading shows increased gene expression in FOXP3 2-day cells compared with the others.

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Yamamoto, Y.; Negoro, T.; Tada, R.; Narushima, M.; Hoshi, A.; Negishi, Y.; Nakano, Y. Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4⁺CD25^high T Cells. Biomedicines 2021, 9, 616. https://doi.org/10.3390/biomedicines9060616

AMA Style

Yamamoto Y, Negoro T, Tada R, Narushima M, Hoshi A, Negishi Y, Nakano Y. Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4⁺CD25^high T Cells. Biomedicines. 2021; 9(6):616. https://doi.org/10.3390/biomedicines9060616

Chicago/Turabian Style

Yamamoto, Yoshiki, Takaharu Negoro, Rui Tada, Michiaki Narushima, Akane Hoshi, Yoichi Negishi, and Yasuko Nakano. 2021. "Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4⁺CD25^high T Cells" Biomedicines 9, no. 6: 616. https://doi.org/10.3390/biomedicines9060616

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4⁺CD25^high T Cells

Abstract

1. Introduction